Recent Updates
Recently added Catalysts

Palbociclib administered

Phase 1

Healthy | Small molecule | Other |Pfizer, Inc.|Last Updated: Dec 17, 2013

Target and mechanism

ModalitySmall molecule

Also known as Palbociclib administered Fasted

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

UNCONTROLLED
Total Trials1
Total Enrollment28

FDA Designations

No designations recorded

Clinical trial landscape

Palbociclib administered · 1 trial · 1 indication

Phase 1 1
NCT01904747Characterization Of The Effect Of Food On Palbociclib (PD-0332991) AbsorptionHealthy
COMPLETED28 Analytics
PHASE1COMPLETED
Characterization Of The Effect Of Food On Palbociclib (PD-0332991) Absorption
HealthyUnlock trial analytics

Study Endpoints

Primary Endpoints

Area Under the Curve From Time Zero to Extrapolated Infinite Time [AUC (0 - 8)]
144 hrs

AUC (0 - 8)= Area under the plasma concentration versus time curve (AUC) from time zero (pre-dose) to extrapolated infinite time (0 - 8). It is obtained from AUC (0 - t) plus AUC (t - 8).

Maximum Observed Plasma Concentration (Cmax)
144 hrs

Secondary Endpoints

Area Under the Curve From Time Zero to Last Quantifiable Concentration (AUClast)
144 hrs
Area Under the Curve From Time Zero to Last Quantifiable Concentration [AUC (0-t)]
144 hrs
Area under the Concentration-Time Curve (AUC) from 0 to 72 hrs
144 hrs
Unlock Study Endpoints

Study Design & Arms

MaskingNONE
ModelCROSSOVER
PurposeBASIC_SCIENCE

Treatment Arms

ArmTypeDescription
Palbociclib given to healthy volunteersEXPERIMENTAL -

Interventions

NameTypeDescription
Palbociclib administered FastedDRUGpalbociclib given under fasting 10 hrs overnight; capsule form, 125 mg single dose
Palbociclib administered Fed high calorieDRUGpalbociclib given right after a high fat high calorie meal; capsule form, 125 mg single dose
Palbociclib administered Fed low calorieDRUGpalbociclib given right after a low fat low calorie meal; capsule form, 125 mg single dose
Palbociclib administered Fed moderate calorieDRUGpalbociclib given between moderate calorie meal; capsule form, 125 mg single dose
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to 55 Years
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: * Healthy male subjects and/or female subjects of non-childbearing potential between the ages of 18 and 55 years * Evidence of a personally signed and dated informed consent document indicating that the subject (or a legal representative) has been informed of all pertinent aspec...

Countries:United States
Unlock Eligibility Criteria